Cancer- and treatment-related anemia: Clinical Practice Guidelines in Oncology Academic Article uri icon

Overview

MeSH Major

  • Anemia
  • Erythropoietin
  • Guidelines as Topic
  • Hematinics
  • Neoplasms

abstract

  • Cancer- and treatment-related anemia has received increasing attention, particularly because relationships between anemia and quality of life (QOL) or treatment outcomes are under investigation. This guideline recognizes the multiple etiologies of cancer- and treatment-related anemia, but specifically addresses the treatment of anemia caused by the myelosuppressive effects of chemotherapy and the anemia associated with chronic disease. It provides guidelines for the use of erythropoietic agents in patients with cancer who are receiving chemotherapy. © Journal of the National Comprehensive Cancer Network.

publication date

  • November 2005

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed ID

  • 16316613

Additional Document Info

start page

  • 772

end page

  • 89

volume

  • 3

number

  • 6